Skip to main content

Table 1 Relationship between c-Met/HGF expression and clinicopathological features

From: c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target

Variable

c-Met expression

P-value

HGF expression

P-value

Low

High

Low

High

Age (mean = 64 years old)

<64

15

36

0.769

33

18

0.219

≥64

17

36

28

25

Gender

Male

27

59

0.762

53

33

0.178

Female

5

13

8

10

Smoking historya

Presence

27

56

0.802

49

34

0.987

Absence

5

12

10

7

Alcohol consumption historya

Presence

25

54

0.77

49

30

0.116

Absence

6

11

7

10

Tumor sizeb (mean = 48.7 mm)

<48.7

20

38

0.357

35

23

0.694

≥48.7

12

34

26

20

Tumor differentiationb

Well

9

17

0.831

10

16

0.024c

Moderate

18

45

39

24

Poor

5

10

12

3

Growth patternb

INFa

8

18

0.901

16

10

0.568

INFb

18

43

37

24

INFc

6

11

8

9

Lymphatic invasionb

ly0

8

23

0.475

22

9

0.097

ly1–3

24

49

39

34

Vessel invasionb

v0

11

15

0.141

16

10

0.73

v1–3

21

57

45

33

Tumor depthd

T1/T2

17

20

0.013c

27

10

0.028c

T3/T4

15

52

34

33

Lymph node metastasisd

N0

13

23

0.39

27

9

0.014c

N1

19

49

34

34

Distant metastasisde

M0

29

66

0.862

58

37

0.107

M1

3

6

3

6

Pathological staged

I/II

23

32

0.010c

38

17

0.022c

III/IV

9

40

23

26

HGF expression

Low

21

40

0.336

   

High

11

32

  
  1. HGF hepatocyte growth factor, INF infiltration
  2. aData were not available for a few patients
  3. bHistopathological features based on the Japanese Classification of Esophageal Cancer, 10th edition (Japan Esophageal Society 2009)
  4. c indicates statistical significance
  5. dTumor-node-metastasis (TNM) classification based on the 6th edition of the TNM classification of malignant tumors [31]
  6. eAll cases of distant metastasis were that of the supraclavicular lymph nodes